Therapies for Down Syndrome Regression Disorder
NCT05662228
Abnormalities, Multiple, Autoimmune Diseases
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT01041469
The purpose of the study is to identify biological data linked to auto immune abnormalities associated with Down Syndrome.
Looking for future studies?
Notify Me8 year–36 year
All sexes
Observational
Institut Jerome Lejeune, Paris, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: at enrolment
Time frame: at enrolment
Institut Jerome Lejeune
Other
Acronym: IMMUTRI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05662228
Abnormalities, Multiple, Autoimmune Diseases
Los Angeles, California, United States
View Trial DetailsNCT04246372
Abnormalities, Multiple, Alopecia
Aurora, Colorado, United States
View Trial DetailsNCT05098600
Abnormalities, Multiple, Alopecia
Prague, Czechia
View Trial DetailsNCT02421276
Abnormalities, Multiple, Autoimmune Diseases
Denver, Colorado, United States
View Trial Details